Sirona Biochem Corp V.SBM

New info out

[wexworth]

now is time to check corporate presentation update on their website. when 0.2% was approved I believe we had a nice run after. Stars are aligning here nicely.

[MirrorWorldMan]

Nothing  new in the presentation, they are just releasing the same slides prior to the investor meeting.  No BIg Deal.  Again, dates of commercial launch, Balamce Sheets, projected financing and dilution etc and expected revenues this year is what everyone really wants to see.  Dont expect any price surge with these sides, I have seen far better in othter BioTechs..

[wexworth]

it says the 0.4% trial is nearing completion. Am I missing something here because you can take any biotech on the planet, and when they release positive clinical results (to be determined in this case), their share prices go up, and depending upon the nature of the results, goes way up. You are certainly welcome to your widget factory comparison.

[JohnFriesen]

This post has been removed in accordance with Community Policy

[MirrorWorldMan]

We are missing much. Like forecasted revenues, details of financials, details of partnershil agreements; timelines for commercializations, manufacturing agreements, quantities produced or guaranteed,  costs of goods, etc etc. Call it super secret if you like, regardless of the reasons. No numbers equals no share price.  I call it super boring and non informative. Same old BE. Is the non

[lscfa]

Can't trust mgmt. When the 0.2% results came out mgmt did not mention that 1067 failed to lighten skin other than dark spots. Shareholders found out about this much later when the study was finally published for all to see.   

[wexworth]

isn't that a good thing in the context of the global black lives matter movement and the fact that all major cosmetic companies are looking for a better, more socially responsible and safe product? Is it also possible that the 0.4% pharma grade product performs a little differently and is more desired in the Asian market? I don't know about you, but since day 1 they have referred to a

[lscfa]

Also, I think the R+F contract is delayed due to 0.4% trials. I no longer believe mgmt BS in Dec 2019 NR.  Recall Obagi cancelled its contract when Sirona went and produced a better version of the skin ligthener.    Dec 2, 2019 - "The planned clinical trial is anticipated to be a value-add for the compound. Current licenses and ongoing product development by partners for

[wexworth]

I don't think so. Sorry, 100% fake news.

[MirrorWorldMan]

Interesting observation isfca, Howie talk was that 1067 is not delayed at all due to upcoming.4% results. Its just going to be so delayed anyway that the .4% trial will be completed regardless. The launch of 1067 is not mentioned in the 5 month objectives set out by Howie, therefore it cannot be expected. 

[wexworth]

I have confirmed a few times with the company about this. The reason why Rodan is not mentioned is related to them not being permitted legal to mention any reference to launch dates in any public documents. No other reason. But I can see why a few are throughing around mistruths as the price right now is a little higher than the 21 cents and that profit train has left the station.

[JohnFriesen]

This post has been removed in accordance with Community Policy

[wexworth]

are you going to stop please, you are embarrassing yourself and you don't seem to register that. there are about 40 high stakes investors laughing at you and your nonsense, why? because they tell me that routinely. Nobody with highly valued perspectives wants to post here anymore because of you. Everyone is missing out on a good exchange because of you. Just stop.

[JohnFriesen]

This post has been removed in accordance with Community Policy

[lscfa]

If 0.4% is not delaying R+F then something else is. Mgmt misled us in Sept 2019 to think launch was imminent, then covered up by saying launch date has never changed.       November 30, 2020 - 01:25 PM 97 Reads  Post# 32001488 RE:Solid Update Co. says it has known about R+F launch date from the beginning and it has not changed so

[wexworth]

no, they said that production would begin later in 2020, the ramp up full production capacity in 2021 to meet demand for significant quantities - it's in a news release. The fact that Wuxi is now in production mode is the key trigger between interim supply (roowin) and core production supply (Wuxi). We need to settle down and let it all come to light.